A Healio article focusing on the top pulmonology-related U.S. Food and Drug Administration (FDA) stories for 2025 included one on the clinical implications of the FDA’s approval of a label update for Winrevair and accompanying perspective from Mohammed Andaleeb Chowdhury, MD, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University.
IMPORTANT: Labor & Delivery services have moved from Temple University Hospital–Main Campus (Broad & Ontario) to our new women & families hospital.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH